These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35820543)

  • 1. IFNγ-induced PD-L1 expression in ovarian cancer cells is regulated by JAK1, STAT1 and IRF1 signaling.
    Padmanabhan S; Gaire B; Zou Y; Uddin MM; Vancurova I
    Cell Signal; 2022 Sep; 97():110400. PubMed ID: 35820543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression.
    Garcia-Diaz A; Shin DS; Moreno BH; Saco J; Escuin-Ordinas H; Rodriguez GA; Zaretsky JM; Sun L; Hugo W; Wang X; Parisi G; Saus CP; Torrejon DY; Graeber TG; Comin-Anduix B; Hu-Lieskovan S; Damoiseaux R; Lo RS; Ribas A
    Cell Rep; 2017 May; 19(6):1189-1201. PubMed ID: 28494868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFNγ induces Bcl3 expression by JAK1/STAT1/p65 signaling, resulting in increased IL-8 expression in ovarian cancer cells.
    Gaire B; Padmanabhan S; Zou Y; Uddin MM; Reddy SU; Vancurova I
    FEBS Open Bio; 2023 Aug; 13(8):1495-1506. PubMed ID: 37151134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFNγ induces JAK1/STAT1/p65 NFκB-dependent interleukin-8 expression in ovarian cancer cells, resulting in their increased migration.
    Padmanabhan S; Gaire B; Zou Y; Uddin MM; DeLeon D; Vancurova I
    Int J Biochem Cell Biol; 2021 Dec; 141():106093. PubMed ID: 34626802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression.
    Xu P; Xiong W; Lin Y; Fan L; Pan H; Li Y
    Cell Death Dis; 2021 Aug; 12(8):779. PubMed ID: 34365463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma.
    Moon JW; Kong SK; Kim BS; Kim HJ; Lim H; Noh K; Kim Y; Choi JW; Lee JH; Kim YS
    Sci Rep; 2017 Dec; 7(1):17810. PubMed ID: 29259270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of PD-L1 Transcriptional Regulation in Ovarian Cancer Cells by Chromatin Immunoprecipitation.
    Zou Y; Padmanabhan S; Vancurova I
    Methods Mol Biol; 2020; 2108():229-239. PubMed ID: 31939185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoblotting Analysis of Intracellular PD-L1 Levels in Interferon-γ-Treated Ovarian Cancer Cells Stably Transfected with Bcl3 shRNA.
    Padmanabhan S; Zou Y; Vancurova I
    Methods Mol Biol; 2020; 2108():211-220. PubMed ID: 31939183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse correlation between TP53 gene status and PD-L1 protein levels in a melanoma cell model depends on an IRF1/SOX10 regulatory axis.
    Martinkova L; Zatloukalova P; Kucerikova M; Friedlova N; Tylichova Z; Zavadil-Kokas F; Hupp TR; Coates PJ; Vojtesek B
    Cell Mol Biol Lett; 2024 Sep; 29(1):117. PubMed ID: 39237877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow Cytometry Analysis of Surface PD-L1 Expression Induced by IFNγ and Romidepsin in Ovarian Cancer Cells.
    Padmanabhan S; Zou Y; Vancurova I
    Methods Mol Biol; 2020; 2108():221-228. PubMed ID: 31939184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma.
    Xiao G; Jin LL; Liu CQ; Wang YC; Meng YM; Zhou ZG; Chen J; Yu XJ; Zhang YJ; Xu J; Zheng L
    J Immunother Cancer; 2019 Nov; 7(1):300. PubMed ID: 31727135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurons upregulate PD-L1 via IFN/STAT1/IRF1 to alleviate damage by CD8
    Wang Y; Shen Y; Liang J; Wang S; Huang Y; Zhu Q; Zhang X; Yu K; Tong G; Yang C; Li Y; Wang J; Zhao Y
    J Neuroinflammation; 2024 May; 21(1):119. PubMed ID: 38715061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity.
    Wu Y; Zhou L; Zou Y; Zhang Y; Zhang M; Xu L; Zheng L; He W; Yu K; Li T; Zhang X; Chen Z; Zhang R; Zhou P; Zhang N; Zheng L; Kang T
    Nat Cancer; 2023 Mar; 4(3):382-400. PubMed ID: 36894639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissection of PD-L1 promoter reveals differential transcriptional regulation of PD-L1 in VHL mutant clear cell renal cell carcinoma.
    Kong SK; Kim BS; Lim H; Kim HJ; Kim YS
    Lab Invest; 2022 Apr; 102(4):352-362. PubMed ID: 34789838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proto-oncogene Bcl3 induces immune checkpoint PD-L1 expression, mediating proliferation of ovarian cancer cells.
    Zou Y; Uddin MM; Padmanabhan S; Zhu Y; Bu P; Vancura A; Vancurova I
    J Biol Chem; 2018 Oct; 293(40):15483-15496. PubMed ID: 30135206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor induces STAT1 expression to exacerbate the IFNr-mediated PD-L1 axis in epidermal growth factor receptor-positive cancers.
    Cheng CC; Lin HC; Tsai KJ; Chiang YW; Lim KH; Chen CG; Su YW; Peng CL; Ho AS; Huang L; Chang YC; Lin HC; Chang J; Chang YF
    Mol Carcinog; 2018 Nov; 57(11):1588-1598. PubMed ID: 30035369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral Delivery of an Adenoviral Vector Carrying the
    Nakagawa S; Serada S; Kakubari R; Hiramatsu K; Sugase T; Matsuzaki S; Matsuzaki S; Ueda Y; Yoshino K; Ohkawara T; Fujimoto M; Kishimoto T; Kimura T; Naka T
    Mol Cancer Ther; 2018 Sep; 17(9):1941-1950. PubMed ID: 29891489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of programmed death-ligand 1 expression in primary normal human dermal fibroblasts after DNA damage.
    Hagiwara Y; Sato H; Permata TBM; Niimi A; Yamauchi M; Oike T; Nakano T; Shibata A
    Hum Immunol; 2018 Aug; 79(8):627-631. PubMed ID: 29859207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide reduces PD-L1 through the EGFR and IFN-γ/IRF1 dual signaling pathways.
    Xie Y; Ding J; Gao J; Zhang J; Cen S; Zhou J
    Int Immunopharmacol; 2023 May; 118():109993. PubMed ID: 36931170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between interferon regulatory factor 1 and BRD4 in the regulation of PD-L1 in pancreatic stellate cells.
    Ebine K; Kumar K; Pham TN; Shields MA; Collier KA; Shang M; DeCant BT; Urrutia R; Hwang RF; Grimaldo S; Principe DR; Grippo PJ; Bentrem DJ; Munshi HG
    Sci Rep; 2018 Sep; 8(1):13225. PubMed ID: 30185888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.